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Background: Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) globally. Diabetes and human
immunodeficiency virus (HIV), both prevalent in South Africa, have not been reported as significant causes of ESRD.
Methods: We evaluated chronic kidney disease (CKD) and cardiovascular disease risk factors in a cross-sectional
study of 302 patients (165 females/ 137 males) at a CKD clinic in rural northern KwaZulu-Natal. We included all
CKD outpatient clinic attendees and excluded acute renal failure patients. Demographic, clinical and laboratory
data collected were analyzed with Stata11 software. Logistic regression analysis was used to determine factors associated
with advanced CKD and results expressed as the odds ratio with the 95% confidence interval [OR (95% CI)].
Results: Of 302 patients analyzed, 290 (96%) were black African. Mean age ± SD was 47.1 ± 17.0 years. Approximately
86.4% of females and 54.5% of males were overweight/ obese. Dyslipidaemia was observed in 47.9% females and
29.2% males (P < 0.001). Estimated glomerular filtration rate (eGFR) was <30 ml/min/1.73 m2 in 50.6% patients.
CKD risk factors observed were: hypertension (77.8%), diabetes (29.8%), HIV (28.5%), glomerulonephritis (7.0%) and
tubulointerstitial diseases (5.6%). Independent factors associated with eGFR <30 ml/min/1.73 m2 at presentation were:
HIV [OR = 2.4 (1.3-4.2), P = 0.004] and hypertension [OR = 2.3 (1.3-4.2), P = 0.007].
Conclusion: Diabetes and HIV are prevalent in CKD patients at primary/regional level healthcare in South Africa. With
registry data lacking, dedicated CKD clinics at lower healthcare levels may provide valuable data on CKD epidemiology
including changes in aetiology. Primary healthcare practitioners are faced with advanced CKD patients in resource-poor
settings, with limited opportunity for upward referral hence the need for nephrology outreach programs.
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Hypertension and glomerulonephritis were the major
causes of end-stage renal disease (ESRD) among South
Africans in previous registry data [1]. In contrast, data
have shown type 2 diabetes as the commonest cause of
ESRD globally, accounting for up to 40% [2]. This has
been in parallel with the global increase in the preva-
lence of obesity and type 2 diabetes. The prevalence of* Correspondence: madalan@ukzn.ac.za
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unless otherwise stated.obesity and diabetes in South Africa has been reported
to be high [3]. Data have also shown that mortality from
diabetes increased by 38% in the period from 1999 to
2006 with an even greater increase of 67% reported for
mortality due to kidney diseases [4]. Diabetic patients have
been under-represented in registry data hence accurate
data on the prevalence of diabetes in the South African
ESRD population are lacking. A study in the Western Cape
province reported that <20% of diabetic patients assessed
for renal replacement therapy (RRT) between 1988 and
2003 were offered RRT, consequently diabetic patients only
comprised 6.2% of accepted patients overall [5].
Human immunodeficiency virus (HIV) infection is an-
other ESRD cause under-represented in local data since
HIV patients were previously excluded from RRT andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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nomic and health consequences of CKD are well-
documented globally [7,8]. Apart from the high costs of
RRT, the pressure on national resources is further
compounded by the high cardiovascular disease (CVD)
burden observed in CKD patients. Consequently, con-
certed global efforts aimed at CKD screening and early
diagnosis have been called for [9]. Screening of the
general population for CKD has not been considered
cost-effective hence many CKD screening programs
often target individuals and groups characterized by a
high CKD prevalence [10]. Variable success rates have
been reported from countries worldwide, including
South Africa, with the best prospects for sustainability
observed in programs that could be incorporated into
national health policy [11,12]. Therefore, epidemiological
data are needed in South Africa to provide the necessary
framework for incorporating CKD early detection and
management into primary level healthcare with other
chronic non-communicable diseases. Our aim was to
describe the prevalence of CKD and CVD risk factors
and determine factors associated with CKD severity in
patients presenting at a CKD clinic in the predominantly
rural northern KwaZulu-Natal region, South Africa.
Methods
Study design and setting
This was a cross-sectional analysis of records kept at
the clinic of consecutive outpatients seen at the dedi-
cated CKD clinic at Ngwelezana hospital situated in the
Uthungulu district, 5 km from the town of Empangeni
and approximately 200 km north of Durban, in
KwaZulu-Natal province, South Africa. The hospital
provides district (primary) level and regional (secondary)
level healthcare services to 20 district hospitals that pro-
vide primary healthcare services to the approximately 2
million people living in the northern KwaZulu-Natal dis-
tricts of Uthungulu, Zululand as well as Umkhanyakude.
The majority live in rural areas with the proportion of
the population living in urban areas estimated at 14.5%,
13.4% and 3.8%, for Uthungulu, Zululand and Umkha-
nyakude, respectively [13]. The region is largely poorly-
resourced with the latter 2 ranked among the 10 most
deprived districts in South Africa in 2007 [14]. Only
acute peritoneal dialysis through a rigid catheter was
offered at Ngwelezana hospital and only a minority of
patients could access RRT in the academic tertiary level
nephrology unit in Durban. The clinic, established by
a specialist physician in 2008 to improve early CKD
identification, had junior doctors, nurses, a social
worker, dietician and visiting nephrologist weekly ini-
tially, with less frequent visits later. The University of
KwaZulu-Natal Biomedical Research Ethics Committee
approved the study.Patients
We reviewed records, kept at the CKD clinic, of all pa-
tients seen from 31st January 2008 to 31st January 2011.
All patients presenting to the clinic were referred by pri-
mary healthcare doctors from any of the 20 district hos-
pitals in the geographic area served by the hospital.
Referral was at the discretion of the primary healthcare
doctor and each patient presented with a referral letter
from the referring doctor providing details of the clinical
diagnosis made, results of investigations performed at
the referring hospital as well as their current medication.
All referrals to our clinic were for kidney disease based
on clinical as well as structural evidence of kidney
disease noted at the referring hospital, including protein-
uria and elevated serum creatinine levels. At first presen-
tation to our clinic, all patients underwent clinical
assessment (history and examination) and laboratory
investigations were done as part of standard care. Renal
disease aetiology was largely determined clinically as
renal histology was unavailable except where glomerulo-
nephritis unrelated to HIV was suspected and those pa-
tients were referred to the tertiary center in Durban for
a renal biopsy. Renal ultrasound services were available
intermittently and were accessed when that was feasible.
Inclusion criteria were: Patients with a diagnosis of
CKD
Exclusion criteria were: Diagnosis of acute renal failure
Data collection
The following data were recorded for each patient.
a. Demographic characteristics: Age, gender, ethnicity,
source of referral, area of residence and smoking
status, where ethnicity was used according to
Census population classification data: African
(black), white, Indian and coloured [13]. Referral
source was categorized according to location of
the referring hospital into: (i) Uthungulu district,
in which the CKD clinic was located, (ii)
Umkhanyakude and (iii) Zululand. Patients were
classified as urban or rural based on Census
definitions of their place of residence [13]. Smoking
was recorded as (i) never smoked/ex-smoker and
(ii) current smoker.
b. History: Medical history, such as hypertension,
diabetes, HIV, dyslipidaemia and medication. Patient
records, referral documents, current medication and
pharmacy entries were used in conjunction with
self-reported history to establish the diagnosis.
c. Physical examination: Anthropometric measures
[weight (kg), height (cm), waist circumference (cm)
and body mass index = weight/height2 (kg/m2)],
blood pressure (mmHg) and dipstick analysis for
proteinuria. Overweight/obese was defined as
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circumference ≥80 cm in females and ≥92 cm in males.
d. Laboratory tests: Results of blood tests recorded
were - serum creatinine, total cholesterol, serum
albumin and haemoglobin. Total cholesterol
>5.0 mmol/l was included in dyslipidaemia definition.
Serum creatinine results were obtained prior to the
implementation of the IDMS-traceable assay and
values were not recalibrated to be IDMS-traceable.
The abbreviated Modification of Diet in Renal Disease
(MDRD) and Schwartz equations were used to
calculate eGFR in patients aged ≥18 years and
<18 years, respectively:
1. MDRD‐eGFR mL=min=1:73 m2ð Þ ¼ 186
 Serum creatinine=88:4ð Þ‐1:154  Ageð Þ‐0:203
 0:742 if femaleð Þ  1:212 if African Americanð Þ
[15]
2. Schwartz ‐ eGFR (mL/min/1.73 m2) =
k x (height in cm) ÷ Serum creatinine [16]
The African-American coefficient was omitted follow-
ing evidence that this improved MDRD-eGFR equation
accuracy in Africans [17-19].
Definitions
CKD was defined by eGFR <60 ml/min/1.73 m2 and/or
proteinuria and/or abnormal renal ultrasound, persistent
for ≥3 months.
Acute renal failure was defined by complete recovery
of kidney function on subsequent visits after initial
presentation.
Statistical analysis
Intercooled Stata version 11 (Texas, USA) was used for
data analysis. Categorical data were described as propor-
tions and males compared with females using the chi-square
test. Continuous data were summarized as mean ± standard
deviation (SD) with the t-test used to assess differences be-
tween males and females. Non-normal data were expressed
as median (interquartile range) and differences between the
two groups were evaluated using the Mann–Whitney test.
Odds ratios (95% CI) were calculated using logistic regres-
sion analysis to evaluate the factors associated with pre-
senting with a low eGFR (<60- and <30 ml/min/1.73 m2).
Results
A total of 313 CKD patients, 174 (55.6%) females and
139 (44.4%) males, were seen on their first visit during
the study period (mean age 47.1 ± 17.0 years). Data were
available for 302/313 (96.5%) patients that were included
in the analysis and 11 patients were excluded due to un-
availability of clinical and/or laboratory data. The ethnic
distribution of study patients was: 290/302 (96%) African
(black), 4 (1.3%) Indian and 8 (2.7%) white. This closelyresembled the population distribution in the 3 districts
comprising northern KwaZulu-Natal [13]. Almost two-
thirds, 191 (63.3%) were referred from Uthungulu dis-
trict while 85 (28.2%) and 26 (8.6%) were from various
hospitals across Umkhanyakude and Zululand districts,
respectively. Over half, 165 (54.6%) were classified as
urban and 137 (45.4%) as rural. Table 1 shows clinical
and laboratory characteristics at presentation by gender.
Significantly more males than females reported current
smoking while females were more likely than males to
have the CVD risk markers of being overweight/obese
and having dyslipidaemia. Over 70% presented with
stage 3 CKD or worse with the presenting median eGFR
(IQR) being 28.9 (49.8) ml/min/1.73 m2.Aetiology of CKD and co-morbid risk factors
Figure 1 shows that the 3 commonest diagnoses encoun-
tered were: hypertension in 227 (75.2%), diabetes in 90
(29.8%) and HIV in 86 (28.5%) with similar gender
distribution. Self-reported history was verified in all
patients using medical records. Renal diagnoses in 21
patients referred for renal biopsy were: primary glomer-
ulonephritis (16), hepatitis B virus-associated (4) and
lupus nephritis (1). Tubulointerstitial diseases were ob-
served in 17 (5.6%) with autosomal dominant polycystic
kidney disease (11), obstructive uropathy (5) and pre-
sumed analgesic nephropathy (1). Hypertension and dia-
betes increased with age while HIV was prevalent in
young patients (Figure 2). Multiple concomitant CKD
risk factors were common (51.1%); dual co-morbidities
in 136 (47.9%) patients and triple co-morbidities in 9
(3.2%). CKD was attributed to a single cause in 139
(48.9%) patients; 87/302 (28.8%) had hypertension alone,
32/302 (10.6%) had HIV alone while glomerulonephritis
alone and tubulointerstitial disease were uncommon; 9/
302 (3.0%) and 5/302 (1.7%), respectively (Figure 3).
Only 6/90 (6.7%) diabetic patients had diabetes alone
with concurrent hypertension in 76 (84.4%) and concur-
rent HIV in 8 (8.9%). Hypertension was a co-morbid
diagnosis in >50% of patients with HIV, glomeruloneph-
ritis and tubulointerstitial disease as well (Figure 3).Other cardiovascular disease risk factors
Dyslipidaemia was found in 118 (39.1%) patients overall
and there was no difference in the various CKD stages
(P = 0.637). In 226 patients with available data to deter-
mine overweight/obese status, prevalence of dyslipidae-
mia was 44.2% in overweight/obese patients and 28.6%
in those who were not, P = 0.032. Fifteen patients
(6 males and 9 females) had CVD complications; stroke
(8), congestive cardiac failure (6) and atherosclerotic re-
novascular disease (1).
Table 1 Distribution of demographic, clinical and laboratory data of study patients by gender
Parameter Male n = 137 Female n = 165 P-value
African 130 (94.9%) 160 (97.0%) 0.282
Rural 60 (43.8%) 77 (46.7%) 0.618
Smoking# 24/134 (17.9%) 2/158 (1.4%) <0.001
Age (years) 45.0 ± 17.6 48.5 ± 16.8 0.055
Systolic blood pressure (mmHg) 144.6 ± 28.3 141.1 ± 25.5 0.362
Diastolic blood pressure (mmHg) 84.2 ± 18.1 81.0 ± 19.0 0.153
BMI (kg/m2)# 25.4 ± 5.5 29.4 ± 7.9 <0.001
Waist circumference (cm)# 92.5 ± 15.2 98.5 ± 20.6 0.021
Overweight/obese# 55/101 (54.5%) 108/125 (86.4%) <0.001
(% with data) (73.7) (75.8)
Dyslipidaemia 40 (29.2%) 78 (47.9%) 0.001
Total cholesterol (mmol/l)* 4.1 (3.5-5.1) 4.5 (3.7-6.0) 0.009
Serum creatinine (μmol/l)* 215 (116–464) 173 (90–336) 0.009
MDRD-eGFR (ml/min/1.73 m2)* 28.5 (11.8-61.9) 30.4 (13.7-63.5) 0.906
% with MDRD-eGFR <60 100 (73.0%) 119 (72.6%) 0.933
% with MDRD-eGFR <30 68 (49.6%) 85 (51.5%) 0.745
% with MDRD-eGFR <15 44 (31.9%) 49 (29.9%) 0.707
Proteinuria 66 (48.2%) 68 (41.2%) 0.225
Serum albumin (g/l) 30.6 ± 9.6 31.3 ± 8.8 0.530
Haemoglobin (g/dl) 10.7 ± 2.7 10.3 ± 2.4 0.183
#Variables with incomplete data; the proportions with available data for smoking, BMI and waist circumference were 97.8%, 54% and 66.4%, respectively,
for males while for females data were available in 95.8%, 59.4% and 67.9%, respectively.
Continuous data were summarized as mean ± SD and non-normal data* as median (IQR); the 25th-75th percentiles are specified rather than the range. Categorical
data were expressed as number (%).
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Figure 4 shows that eGFR was highest in younger pa-
tients and decreased with increasing age [OR = 0.48
(0.37-0.62) per 10-year, P <0.001] but there was no sig-
nificant age difference in those presenting with eGFR
<15 ml/min/1.73 m2 (P = 0.099). Using logistic regres-
sion analysis, independent factors associated with eGFR
<60 ml/min/1.73 m2 at presentation were: age ≥60 years
[OR = 4.5 (2.0-10.5)], HIV infection [OR = 3.0 (1.5-5.9],
hypertension [OR = 2.7 (1.4-5.0] and rural residence
[OR = 1.9 (1.1-3.4)] while a lower presenting eGFR
<30 ml/min/1.73 m2 was strongly associated with HIV
as well as hypertension but not with age or residence
(Table 2). Disease severity at presentation was not sig-
nificantly associated with gender, diabetes or referral
source.
Discussion
This is the first study in South Africa to report high
prevalence estimates for diabetes and HIV, 29.8% and
28.5%, respectively in a single patient cohort at a sec-
ondary level healthcare-based dedicated CKD clinic. Our
observations add important data on CKD epidemiology
outside of a tertiary level nephrology environment,particularly because diabetes and HIV have mostly been
under-represented in previous studies. In two recent
studies, diabetes was observed in 10.8% of patients in
the Free State province and <5% of renal biopsies in the
Western Cape province while HIV-associated nephropa-
thy (HIVAN) was high in the latter study, comprising
25.7% of annual renal biopsies in 2009 [20,21]. Most
HIV patients in the present study were presumed to
have HIVAN since renal biopsy was largely not access-
ible, which was based on a previous study from our in-
stitution that showed HIVAN in >80% of HIV patients
with microalbuminuria or overt proteinuria [22].
Dedicated CKD clinics typically conducted at tertiary
level by nephrologists were inaccessible to most patients
in this study due to various healthcare resource con-
straints hence the establishment of this CKD outreach
clinic. Published South African experience of nephrology
outreach is limited to a study in Soweto primary health-
care clinics in Gauteng province that found eGFR
<60 ml/min/1.73 m2 in 26% and nephrotic-range pro-
teinuria in 9% of patients evaluated [12]. The high pro-
portion of patients with advanced disease (50.6% with
eGFR <30 ml/min/1.73 m2) in our clinic highlights an

















Figure 1 Prevalence of CKD risk factors in the 302 study patients.
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unable to access tertiary care, thus primary healthcare
practitioners are managing increasingly complex patients.
The strong association of HIV and hypertension with a
low presenting eGFR level in this study may be due to
late referral or it may suggest a high risk for CKD pro-
gression in this population. In a recent systematic re-
view, independent risk factors for late referral in CKD
included older age, multiple comorbidities, renal disease
aetiology and lower socioeconomic status [23]. Older
age and rural residence (an indicator of poor socioeco-
nomic status) were independent factors associated with
presenting with stage 3 CKD or worse in our study. Only
45% of clinic patients were classified as rural while over
















Figure 2 Distribution of hypertension, diabetes and HIV by age groupwere rural. The discrepancy may be because >60% of
referrals were from within the district where the CKD
clinic is located, which might suggest disproportionately
greater access to the clinic by the urban minority
population or a higher CKD prevalence in urban com-
munities; both postulates need further evaluation in
population-based studies. The strong association ob-
served between older age and lower eGFR remained
significant even after adjusting for hypertension and dia-
betes, both of which increased in prevalence with age.
Hypertension prevalence also increases with worsening
CKD, which was also observed in the present study with
hypertension found in 80.5% in patients with stage 3
CKD and 85% of those with stage 5 CKD. These findings





Figure 3 Distribution and overlap of major CKD risk factors in patients with one or more co-morbidities.
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prevalence was 86.8% in stage 3 CKD, increasing to
95.5% in stages 4–5 [24].
The high prevalence of advanced CKD in the our
study could reflect rapid CKD progression as patients
were almost exclusively black (96%) thus at high risk for
more severe hypertensive target organ damage, including
CKD, as reported in black South Africans [25]. However,
CKD progression could not be evaluated in this present
study design. Hypertension alone was again shown in
this study as the commonest cause of CKD, as in many
other studies in black South Africans and other sub-
Saharan populations [20,26-29]. Although clinical diag-
nosis was adopted in this study, there is evidence from
published biopsy data for hypertensive nephrosclerosis
as the major ESRD cause in black South Africans





















Figure 4 Distribution of patients grouped according to presenting eG
75th percentiles in various age groups.ancestry (black race) is also associated with aggressive
CKD in HIV patients. HIV infection in black patients
was associated with a greater risk for incident CKD,
higher prevalence for more aggressive disease with faster
progression to ESRD and worse CKD outcome than in
white patients [30]. Studies are needed in South Africans
to evaluate progression of CKD in HIV patients, particu-
larly as CKD patients with HIV were younger (mean age
39.5 ± 11.9 years in HIV patients versus 47.1 ± 17.0 years
in the overall cohort). The weak association of diabetes
with CKD observed in the present study contrasts with
the overwhelming evidence in the literature and was
probably because too few patients (<10%) had diabetes
alone. This could reflect under-recognition or lack of re-
ferral of patients with diabetic CKD without concurrent
hypertension but there are no published studies in this
region to support this speculation thus far. Elsewhere,40 50 60
 (years)
FR level and age. The box-and-whisker plot shows the 25th, 50th and
Table 2 Multivariable logistic regression analysis results showing factors associated with presenting eGFR <60 and
<30 ml/min/1.73 m2
Risk factor MDRD–eGFR <60 MDRD–eGFR <30
Adjusted OR (95% CI) P–value Adjusted OR (95% CI) P–value
Age ≥60 years 4.5 (2.0–10.5) <0.001 1.4 (0.8–2.5) 0.261
HIV 3.0 (1.5–5.9) 0.001 2.4 (1.3–4.2) 0.004
Hypertension 2.7 (1.4–5.0) 0.002 2.3 (1.3–4.2) 0.007
Rural 1.9 (1.1–3.4) 0.021 1.5 (0.9–2.4) 0.100
Diabetes 1.7 (0.8–3.3) 0.148 1.3 (0.7–2.2) 0.415
Male gender 1.2 (0.7–2.1) 0.493 1.0 (0.6–1.6) 0.998
Referral source 1.3 (0.9–1.8) 0.131 1.2 (0.9–1.5) 0.274
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as a barrier yet to be overcome in the global efforts
against CKD, with some surveys in the United States
putting patient awareness of their disease as low as 9.4%
in those with diabetic CKD [2]. Patients with suspected
glomerulonephritis (non-HIV) in our province tend to
be referred directly to the tertiary centre hence the low
prevalence in this study differs from previous reports of
glomerulonephritis as a common cause of CKD in sub-
Saharan Africa [1,5,27,29,31].
The proportion of patients that were overweight/
obese in this study (86.4% in females and 54.5% in
males) was substantially higher than the reported preva-
lence of 58.5% and 25.4% in black South African women
and men, respectively, in the general population [3]. Our
observations were similar to findings in the Soweto
study cited earlier, which reported that 86% of females
and 40.9% of males were overweight/obese using waist
circumference while prevalence was 83% and 75%,
respectively, when using a composite measure of waist
circumference combined with BMI [12]. Our study is
the first to report a high prevalence of dyslipidaemia
(39.1%) in South African CKD patients. The results are
in keeping with the prevalence of dyslipidaemia or
hypercholesterolaemia of 38.4% in sub-Saharan Africa
reported in a recent meta-analysis of 16 studies of high
cardiovascular-risk patients [32]. However, using total
cholesterol to evaluate dyslipidaemia, as in our clinic,
may underestimate the true burden since HDL, triglycer-
ides and apolipoproteins are the major abnormalities
found in CKD [33].
Study strengths and limitations
This study provides important insight into CKD and
CVD risk factors in this population that has not been
studied before. The results add to the much needed
CKD epidemiology data in South Africa in the absence
of RRT registry data and representative population stud-
ies. The study is subject to the inherent limitation of
a cross sectional design in which causal associationscannot be determined between CKD severity and the
various risk factors as the temporal sequence is un-
known. Selection bias may have potentially occurred
from preferential referral of advanced CKD patients over
those with earlier CKD and contributed to the small
sample size thus results may not reflect the true preva-
lence in northern KwaZulu-Natal. Another limitation is
the use of serum creatinine values without re-calibration
to the IDMS assay as this could have introduced bias in
calculating eGFR. Correction to the IDMS method sub-
stantially improves accuracy of MDRD-eGFR, especially
in CKD stages 1–3 although the impact of correction
was shown to be minimal at GFR <45 ml/min/1.73m2
[34]. We expect the bias from non-standardized creatin-
ine to be small in this study, as the median eGFR was
low. This will be eliminated in future studies as all la-
boratories nationally now use standardized serum cre-
atinine in calculating eGFR. The validity of MDRD
eGFR in HIV patients is uncertain thus using MDRD
eGFR in our HIV patients may be a potential limitation.
There are no validation studies in our population and
data from published validation studies in various popula-
tions are inconclusive on the equation that provides the
best GFR estimate. A recent systematic review of studies
that evaluated MDRD eGFR reported that the perform-
ance was similar in HIV-infected and HIV-negative pa-
tients [35]. The absence of renal histology, CD4 cell
count and antiretroviral (ARV) therapy data may also be
a limitation since these may be significant risk factors
for incident CKD as well as progression.
Study implications
The implications of our findings of advanced CKD in
the majority (>70%) of patients, in strong association
with HIV infection and hypertension, is that patients
presenting with these conditions should be screened for
CKD at initial presentation to primary healthcare practi-
tioners and regularly thereafter. The high HIV burden in
South Africa as well as the widespread national ARV
therapy roll-out program with the resultant improving
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significant contributor to the CKD burden. Further re-
search is needed to determine the public health impact
including resource requirements for CKD early detection
and management. The successful integration of HIV care
into the primary healthcare system nationally, even in
resource-poor settings, provides a promising model for
CKD as well, hence integration of CKD screening and
management into the existing HIV infrastructure needs
to be explored as a potentially feasible strategy in man-
aging CKD.
Conclusion
Our results provide evidence for the first time in South
Africa that diabetes and HIV are prevalent in CKD patients
at primary/regional level suggesting that both may be
emerging as significant causes of CKD in South Africans,
following hypertension. The high prevalence of advanced
CKD and other CVD risk factors in this cohort suggests
that increasingly complex patients are being managed at
lower healthcare levels in this region, a trend we expect to
be more widespread in the country because nephrology
services are available only in a few cities. This underscores
the need for dedicated CKD clinics with specialist outreach
support in resource-poor areas where options for upwards
referral and RRT are limited.
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